Across TCGA pan-cancer cohorts, RPSAP60 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPSAP60’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where RPSAP60 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPSAP60 is over-expressed in tumor.
COAD, HNSC, and LUSC are the cancer types where RPSAP60 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPSAP60 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.